Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile.
- 1 January 1998
- journal article
- clinical trial
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 26 (4) , 471-492
- https://doi.org/10.1023/a:1021068202606
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complex*Clinical Pharmacology & Therapeutics, 1997
- A nonparametric subject-specific population method for deconvolution: II. External validationJournal of Pharmacokinetics and Biopharmaceutics, 1995
- A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examplesJournal of Pharmacokinetics and Biopharmaceutics, 1995
- An efficient control strategy for dosage regimensJournal of Pharmacokinetics and Biopharmaceutics, 1994
- Estimation and model selection in constrained deconvolutionAnnals of Biomedical Engineering, 1993
- Targeting the systemic exposure of teniposide in the population and the individual using a stochastic therapeutic objectiveJournal of Pharmacokinetics and Biopharmaceutics, 1993
- PHARMACODYNAMIC MODEL OF TOLERANCE - APPLICATION TO NICOTINE1988
- Implementation and evaluation of control strategies for individualizing dosage regimens, with application to the aminoglycoside antibioticsJournal of Pharmacokinetics and Biopharmaceutics, 1986
- Methods for evaluating optimal dosage regimens and their application to theophylline.1982
- APriori lithium dosage regimen using population characteristics of pharmacokinetic parametersJournal of Pharmacokinetics and Biopharmaceutics, 1979